Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke

Charles Esenwa1, Natalie T Cheng1, Jorge Luna2

  • 1Department of Neurology (C.E., N.T.C., K.K.-T., D.L., A.L.L., P.M., K.M., A.S., A. Lendaris, J.S.), Montefiore Medical Center.

Stroke
|August 25, 2021
PubMed

Insights

This study investigated the impact of [keyword 1] on [keyword 2]. Our findings indicate a significant correlation, suggesting [keyword 3] may play a crucial role.

Area of Science:

  • Biomedical Research
  • Genetics

Background:

  • Understanding the genetic basis of diseases is crucial for developing targeted therapies.
  • Previous research has identified several candidate genes, but their specific roles remain unclear.

Purpose of the Study:

  • To investigate the role of gene X in the pathogenesis of disease Y.
  • To identify potential therapeutic targets for disease Y.

Main Methods:

  • Genome-wide association study (GWAS) in a cohort of patients with disease Y.
  • Functional validation of candidate genes using in vitro and in vivo models.

Main Results:

  • A novel genetic variant in gene X was significantly associated with disease Y.
  • In vitro studies demonstrated that the variant affects protein function.
  • In vivo studies showed that inhibiting gene X ameliorated disease phenotypes.

Conclusions:

  • Gene X is a key player in the pathogenesis of disease Y.
  • Targeting gene X may represent a promising therapeutic strategy for disease Y.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
438
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
48
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.3K